Evogene Ltd. current report, Q3 FY2017

Business Context and Reporting Period

This Form 6-K filing by Evogene Ltd. covers the month of July 2017, with a report date of July 26, 2017. The filing serves to distribute a press release regarding a new strategic partnership.

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a corporate event rather than a financial statement.

Material Changes

The primary material change disclosed is the announcement of a multiyear research collaboration between Evogene Ltd. and DuPont Pioneer. The partnership focuses on the development of corn bio-stimulant products.

Guidance, Outlook, and Risks

The filing does not contain updated financial guidance, management commentary on future performance, or specific risk factors beyond the context of the new collaboration. No unusual items or contingencies are detailed in the provided text.

Investor Verification Points

  • Verify the specific terms, duration, and financial commitments of the DuPont Pioneer collaboration.
  • Confirm the expected timeline for the development and commercialization of the corn bio-stimulant products.
  • Review subsequent filings for any financial impact or milestone payments resulting from this agreement.